ReCode is the first genetic medicines platform to enable highly targeted delivery to organs, tissues and cells beyond the liver. Our pipeline of rare disease therapeutics uses optimized …

ReCODE is more than just a program—it’s your personalized roadmap to reversing early cognitive decline and improving your quality of life. This proven approach combines cutting-edge …

Nov 11, 2025 · The most important part of the [ReCODE] protocol … is that the improvement is sustained. You're actually going after the root cause of what is causing the cognitive decline.

Recode (stylized as recode; formerly Re/code) [1] was a technology news website that focused on the business of Silicon Valley. Walt Mossberg and Kara Swisher founded it in January 2014, …

Oct 17, 2025 · ReCODE stands for Reversal of Cognitive Decline. It’s a precision-medicine program built on 25+ years of research that has identified more than 40 contributors to …

The ReCODE program looks at genetic factors, lifestyle factors, toxin exposures, and nutritional and hormone deficiencies and, by addressing multiple contributors, can reverse early …

ReCode is developing an mRNA-based therapy designed to restore ciliary function in the lungs of people with PCD caused by pathogenic mutations in the DNAI1 gene.

ReCODE (reversing cognitive decline) and PreCODE (prevention of cognitive decline) are personalized therapeutic programs that target and treat the root cause of cognitive decline and …

Mar 25, 2025 · RCT2100 was formulated leveraging ReCode’s proprietary Selective Organ Targeting (SORT) lipid nanoparticle (LNP) platform and is designed to deliver CFTR mRNA …

Taking Apollo Health’s ReCODE 2.0 training will provide you with the tools needed to manage care, identify the specific drivers of cognitive decline, and develop a treatment plan using the …